Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Z. M. Golant"'
Autor:
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich
Publikováno v:
Фармакоэкономика, Vol 17, Iss 1, Pp 106-117 (2024)
The article aims to examine technological, organizational and regulatory aspects of drug quality and safety assurance system, as well as peculiarities in civil circulation of extemporaneous drugs in Latvian pharmaceutical market to improve approaches
Externí odkaz:
https://doaj.org/article/dda0c9863bdc4aeabd6d69c4810b90ec
Autor:
S. E. Erdni-Garyaev, D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, Z. M. Golant, V. S. Fisenko, I. A. Narkevich
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 14, Iss 1, Pp 91-109 (2024)
SCIENTIFIC RELEVANCE. There is a need to move towards an appropriate system of quality assurance in pharmacy compounding. At the same time, the development of a Russian regulatory system for pharmacy compounding requires a broad understanding of inte
Externí odkaz:
https://doaj.org/article/e767d6c440824a6189a585c19e8dd8b5
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 3, Pp 176-192 (2023)
Today the activities of compounding pharmacies in terms of the drug compounding and in-pharmacy packaging of approval drugs is considered as a priority social task of the Russian Federation, due to the need to solve problems that are aimed at ensurin
Externí odkaz:
https://doaj.org/article/1d048504eec848e78574596c70b921f0
Autor:
S. E. Erdni-Garyaev, D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, Z. M. Golant, V. S. Fisenko, I. A. Narkevich
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 0, Iss 0 (2023)
INTRODUCTION. The Russian Federation has decided to restore the system of compounding pharmacies as an element of the critical national healthcare infrastructure and pharmaceutical supply chain. To improve Russian regulatory practices, develop novel
Externí odkaz:
https://doaj.org/article/1e07b55e3a994867b20a1f61de4b86b8
Autor:
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich
Publikováno v:
Фармакоэкономика, Vol 16, Iss 1 (2023)
In order to improve regulation of socially significant type of activity in the field of compounding pharmacy production, the review summarizes the technological, organizational and regulatory requirements for ensuring quality and safety of compoundin
Externí odkaz:
https://doaj.org/article/d4ffbe7505fc4787a08290181f43eb02
Publikováno v:
Фармакоэкономика, Vol 15, Iss 1, Pp 23-39 (2022)
Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs) in the United Kingdom (UK), and proposal development to improve the processes of state regulation of manufacturers’ marginal registered prices of medi
Externí odkaz:
https://doaj.org/article/ce59c12148f74fa8b24c88b53e6fd95a
Publikováno v:
Фармакоэкономика, Vol 13, Iss 2, Pp 193-204 (2020)
Aim. To analyze the methods of the state regulation of prices for the manufacturers of pharmaceutical drugs in the Eurasian Economic Community counties (EAEC).Materials and Methods. The comparison of the aspects of the price regulation was presented
Externí odkaz:
https://doaj.org/article/f6e52f07847a42b090f68ccd9ffd5bbe
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 1, Pp 232-236 (2019)
The article treats and summarizes the knowledge on the regulatory framework and the government procurements practice of medicinal products. The authors established that there are inconsistencies of the implementation of the regulatory requirements fo
Externí odkaz:
https://doaj.org/article/243f29d6b7494f89934159667f2c6b39
Autor:
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
Publikováno v:
Фармакоэкономика, Vol 9, Iss 1, Pp 34-38 (2016)
Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug inclusion and exclusion into the reimbursement lists in Russian Federation. The liner mathematical model of decision making was developed and adopted.A
Externí odkaz:
https://doaj.org/article/f1931e909f9940e6a6b831cdcbde316e
Publikováno v:
Фармакоэкономика, Vol 13, Iss 2, Pp 193-204 (2020)
Aim . To analyze the methods of the state regulation of prices for the manufacturers of pharmaceutical drugs in the Eurasian Economic Community counties (EAEC). Materials and Methods . The comparison of the aspects of the price regulation was present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::428c79afe82b3ec907a2650182405d10
https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.039
https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.039